Financial Toxicity in Patients With Early-stage Breast Cancer
Recruiting
Observational Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 864 (estimated)
- Sponsor
- National Cancer Institute, Naples · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Signed informed consent form
* Age \> 18 years at the time of study entry
* Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment.
Exclusion Criteria:
* Stage IV invasive breast carcinoma
* Major cognitive dysfunction or psychi…
Contacts